GB0107907D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0107907D0 GB0107907D0 GBGB0107907.8A GB0107907A GB0107907D0 GB 0107907 D0 GB0107907 D0 GB 0107907D0 GB 0107907 A GB0107907 A GB 0107907A GB 0107907 D0 GB0107907 D0 GB 0107907D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0107907.8A GB0107907D0 (en) | 2001-03-29 | 2001-03-29 | Novel compounds |
PCT/EP2002/003572 WO2002079190A1 (en) | 2001-03-29 | 2002-03-28 | 3-substituted indoles as chemokine antagonists |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0107907.8A GB0107907D0 (en) | 2001-03-29 | 2001-03-29 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0107907D0 true GB0107907D0 (en) | 2001-05-23 |
Family
ID=9911854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0107907.8A Ceased GB0107907D0 (en) | 2001-03-29 | 2001-03-29 | Novel compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0107907D0 (en) |
WO (1) | WO2002079190A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003004487A1 (en) | 2001-07-02 | 2003-01-16 | Astrazeneca Ab | Piperidine derivatives useful as modulators of chemokine receptor activity |
GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
SE0200843D0 (en) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
SE0200844D0 (en) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
CN1744899A (en) * | 2002-12-13 | 2006-03-08 | 史密丝克莱恩比彻姆公司 | Piperidine derivatives as CCR5 antagonists |
JPWO2004069828A1 (en) * | 2003-02-04 | 2006-05-25 | 三菱ウェルファーマ株式会社 | Piperidine compounds and their pharmaceutical uses |
SE0300850D0 (en) * | 2003-03-25 | 2003-03-25 | Astrazeneca Ab | Chemical compounds |
SE0300957D0 (en) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
DE10337184A1 (en) | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituted 3-pyrrolidine-indole derivatives |
CN101065374A (en) * | 2004-09-28 | 2007-10-31 | 詹森药业有限公司 | Substituted dipiperidine ccr2 antagonists |
EP1994019B1 (en) * | 2005-04-30 | 2011-11-02 | Boehringer Ingelheim International GmbH | Novel piperidin - substituted indoles and their use as ccr-3 modulators |
WO2007011293A1 (en) | 2005-07-21 | 2007-01-25 | Astrazeneca Ab | Novel piperidine derivatives |
US20070197590A1 (en) * | 2006-01-31 | 2007-08-23 | Demong Duane E | Substituted dipiperidine ccr2 antagonists |
PE20090829A1 (en) * | 2007-06-20 | 2009-07-25 | Glaxo Group Ltd | SPIROINDOLINS AS CHEMOKINE RECEPTOR MODULATORS |
WO2010080873A1 (en) * | 2009-01-08 | 2010-07-15 | Glaxo Group Limited | Oxazoles as modulators of chemokine receptors |
ES2880623T3 (en) * | 2009-04-02 | 2021-11-25 | Merck Patent Gmbh | Piperidine and piperazine derivatives as autotaxin inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0927167A1 (en) * | 1996-08-14 | 1999-07-07 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
AU3386500A (en) * | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
-
2001
- 2001-03-29 GB GBGB0107907.8A patent/GB0107907D0/en not_active Ceased
-
2002
- 2002-03-28 WO PCT/EP2002/003572 patent/WO2002079190A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002079190A1 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0105895D0 (en) | Novel compounds | |
AU2002359165A8 (en) | Novel compounds | |
GB0107907D0 (en) | Novel compounds | |
GB0106586D0 (en) | Novel compounds | |
GB0104259D0 (en) | Novel compounds | |
GB0102470D0 (en) | Novel compounds | |
GB0103866D0 (en) | Novel compounds | |
GB0102713D0 (en) | Novel compounds | |
GB0102711D0 (en) | Novel compounds | |
GB0107906D0 (en) | Novel compounds | |
GB0100186D0 (en) | Novel compounds | |
GB0100187D0 (en) | Novel compounds | |
GB0101334D0 (en) | Novel compounds | |
GB0101437D0 (en) | Novel Compounds | |
GB0106158D0 (en) | Novel Compounds | |
GB0102469D0 (en) | Novel compounds | |
GB0100184D0 (en) | Novel compounds | |
GB0102570D0 (en) | Novel Compounds | |
GB0102571D0 (en) | Novel Compounds | |
GB0102575D0 (en) | Novel Compounds | |
GB0102576D0 (en) | Novel compounds | |
GB0100182D0 (en) | Novel compounds | |
GB0100180D0 (en) | Novel compounds | |
GB0102578D0 (en) | Novel Compounds | |
GB0100181D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |